Medidata Blog
Transforming Clinical Development One Study at a Time
August 08, 2016
Reading Time: < 1 minute
The life science industry is under pressure. As key patents are expiring, pharma and biotech companies are challenged to bring new and better treatments to patients. Clinical trials are vital for proving safety and efficacy – but they’re long, complicated and expensive.Watch this video for an overview of Medidata's vision for helping life sciences companies and organizations transform their clinical development process.
TWEET THIS:
VIDEO—With patents expiring, #pharma & biotech companies are challenged to bring new & better treatments to patients. http://t.co/XCJITrxV1Y
— Medidata (@Medidata) February 12, 2015
